Loading...

Gelteq Limited Ordinary Shares

GELS•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$0.70
$0.02(3.37%)
U.S. Market opens in NaNh NaNm

Gelteq Limited Ordinary Shares (GELS) Stock Overview

Explore Gelteq Limited Ordinary Shares’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap6.4M
P/E Ratio0.00
EPS (TTM)$-0.52
ROE-0.43%
Fundamental Analysis

AI Price Forecasts

1 Month$2.09
3 Months$0.53
1 Year Target$0.00

GELS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Gelteq Limited Ordinary Shares (GELS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 47.31, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 0.00 and a market capitalization of 6.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
3.37%
5-Day Change
-0.07%
1-Month Change
-5.84%
3-Month Change
-33.38%
6-Month Change
-43.59%
Year-to-Date (YTD) Change
-12.56%
1-Year Change
-69.85%
3-Year Change
-76.21%
5-Year Change
-76.21%
All-Time (Max) Change
-76.21%

Contact Information

https://www.gelteq.com
61 3 9087 3990
641 Glen Huntly Road, Caulfield, VIC, 3162

Company Facts

7 Employees
IPO DateOct 29, 2024
CountryAU
Actively Trading

Frequently Asked Questions